appreciation still affected sale revenue. Other income of 3rd quarter on 2018 increased 28.04 percent due to higher gain from exchange rate. 1.2 Cost of goods sold and expenses (Thousands Baht) Nine-months
Ramkhamhaeng Hospital Public Company Limited and its subsidiaries are as follows. Unit : Million baht 2020 2019 Cost of medical treatment 1,454.77 617.92 Cost of selling medical equipment 125.25 122.84
Ramkhamhaeng Hospital Public Company Limited and its subsidiaries are as follows. Unit : Million baht 2020 2019 Cost of medical treatment 1,373.18 644.93 Cost of selling medical equipment 166.98 94.11
million decreased by Baht 303.39 million, or 16.42% from the previous year, mainly from the decrease of branches from 106 branches to 97 branches. 2. The Company’ s cost of goods sold in the year 2018 were
increased from THB 82.00 million to THB 133.61 million or increased THB 51.61 million or 62.94% because film production and films rights distribution generated more revenue than last year. Cost and expense of
compared with Q3 year 2017. Cost of Sales for Q3 year 2018 and Q3 year 2017 was 355.25 million baht and 331.79 million baht, respectively. It increased 23.45 million baht or 7.07% when compared with Q3 year
price that decreased due to the global economic slowdown as a result of trade protection measures between China and the United States. - The company has cost of sales of 616.03 million baht or 84.14% of
alternatives for Thai investors and expand markets for Thai asset management companies. This cross-border advancement is also a good indicator that our investment management industry is on par with international
opportunity for business to adapt towards sustainability using technology advancement and also the changes in resources demands during COVID-19 pandemic. In addition, stakeholders, such as investors
cost of sales being the most frequently recurring themes. Many different factors may have led to such persistent deficiencies of some audit firms and auditors. This includes insufficient involvement of